Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical Companies, Hospitals) – Global Forecast to 2025

2020-03-23
Price :
Published : Mar-2020
No. of Pages : 168

“The digital pathology market is projected to grow at a CAGR of 13.2% during the forecast period (2020–2025).”

The global digital pathology market is projected to reach USD 1,139.8 billion by 2025 from USD 613.6 billion in 2020, at a CAGR of 13.2% during the forecast period. The key factors driving the growth of this market include the

increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development & companion diagnostics, and increasing initiatives by industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent.

“Adoption of artificial intelligence is expected to increase during the forecast period.”

The adoption of AI in healthcare has been rising in recent years due to its ability to optimize clinical processes, thereby solving a variety of problems in the healthcare industry. AI helps patients receive correct diagnosis in a timely manner, maximize hospital efficiency, and reduce the waiting time for patients, thereby enhancing overall healthcare. AI helps in collecting, storing, and normalizing data along with tracing its lineage.

“The software segment will grow at the highest rate during the forecast period.”

On the basis of product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the digital pathology market in 2019. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe, and the high cost of scanners. On the other hand, the software segment is projected to witness the highest growth rate during the forecast period, due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis.

“By type, the human pathology segment accounted for the largest share of the digital pathology market in 2019.”

On the basis of type, the global digital pathology market is segmented into human and veterinary pathology. The human pathology segment accounted for the largest share of the digital pathology market in 2019. The increasing number of cancer research activities and growing collaborations between academic research institutes, universities, and pathology laboratories are driving the increased uptake of digital systems in human pathology.

“The market in North America is projected to witness the highest growth rate during the forecast period (2020–2025).”

North America is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the rising prevalence of cancer and increasing initiatives by industry players. On the other hand, the Asia Pacific region is expected to grow at the second-highest CAGR during the forecast period. Factors such as a large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
  • By Category (Demand-side): Pharmaceutical & Biotechnology Companies: 55%, Hospitals and Reference Laboratories: 35%, and Academic & Research Institutes: 10%
  • By Designation: C-level: 35%, Director-level: 25%, and Managers: 40%
  • By Region: North America: 35%, Europe: 32%, Asia: 22%, and the RoW: 11%

Leica Biosystems (US), Koninklijke Philips (Netherlands), and Hamamatsu Photonics K.K. (Japan) are the leading players in the global digital pathology market. Other notable players in this market includeRoche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).

Research Coverage:

The report analyzes the digital pathology market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on the product, type, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the digital pathology market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of digital pathology solutions across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital pathology market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology market.
Filed in: Medical Device
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) – Forecast to 2025

“The European Medical Device market is projected to grow at a CAGR of 4.7 % between 2020 and 2025.” The European medical devices market is projected to reach USD 61.4 billion by 2025 from an estimated USD 48.9 billion in 2020, at a CAGR of 4.7% during the forecast period. Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market. However, fiscal unsustainability due to wasteful spending might hamper the market growth to a certain extent. “Orthopedic device segment to have the largest share during the forecast period.” The ort......
$5650

Centesis Catheters Market by Type (Small and Large bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics and Palliative care), End user (Hospitals, Ambulatory surgery centers), Region – Global Forecast to 2025

“Global centesis catheters market is projected to grow at a CAGR of 6.8%” The global centesis catheters market is projected to reach USD 633 million by 2025 from USD 426 million in 2019, growing at a CAGR of 6.8% from 2019 to 2025. The key factors driving the growth of this market include the rising target patient population (particularly patients suffering from cancer, TB, and cardiovascular diseases), growing preference for image-guided centesis procedures, and the increasing evidence for the efficacy of centesis procedures for target diseases. However, premium product pricing and medical complexities associated with centesis procedures are some of the major factors that are expected to restrain the growth of this market in the coming years. “Small-bore centesis catheters seg......
$5650

Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User, Region-Global Forecast to 2025

“The global veterinary point-of-care diagnostics market is projected to grow at a CAGR of 8.9% during the forecast year.” The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%. The increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for rapid disease detection are the major factors driving the growth of this market. However, the high cost of veterinary imaging instruments is expected to restrain market growth to a certain extent. “The consumables segment dominates the veterinary point-of-care diagnostics market.” Based on product, the veterinary point-of-care diagnostics market is segmented into consumables and instruments. C......
$5650

Veterinary Monitoring Equipment Market by Type (Vital Signs Monitor, Anesthesia Monitor, ECG Monitor), Target Area (Respiratory diseases, Weight Monitoring), Animal Type (Dogs, Cats, Equines), End User (Veterinary Clinic), Region – Global Forecast to 2025

“The veterinary monitoring equipment market is projected to grow at a CAGR of 9.8% during the forecast period (2019–2025).” The veterinary monitoring equipment market is projected to reach USD 570 million by 2025 from USD 326 million in 2019, at a CAGR of 9.8%. The increasing focus on animal health among pet owners and the growing prevalence of diseases among companion animals are the key factors driving market growth. Also, the growing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the rising number of veterinary practitioners & income levels in developed economies are aiding the adoption of veterinary monitoring equipment. “The vital sign monitors segment is expected to grow at the highest rate during the forecast pe......
$5650

Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) – Global Forecast to 2025

“The medical wearables market is expected to grow at a CAGR of 21.4% during the forecast period.” The global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4% during the forecast period of 2020 to 2025. The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population and rising focus on patient-centric healthcare delivery. “Based on device type, the vital signs monitoring segment accounted for the largest share of the market in 2019.” In 2019, the vital signs monitoring segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growing use of high-tech devices, which are compact, user-fri......
$5650

Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), Accessories (Powder, Deodorant)), End User and Region – Global Forecast to 2025

“The ostomy care market projected to grow at a CAGR of 4.4% over the forecast period of 2020-2025.” The ostomy care market is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.4% during the forecast period. Globally, the population of individuals aged 60 years and above is expected to increase from 962 million in 2017 to 2.1 billion by 2050 (Source: UN Population Division). The rising geriatric population is considered as one of the major factors driving the growth of the ostomy care industry, as the incidence of bladder cancer and colorectal cancer is high among geriatric individuals. Thus, the rising geriatric population, coupled withthe growing number of awareness programs to educate patients regarding the use of ostomy products,are the major......
$6780

Healthcare / Medical Simulation Market by Product & Services (Patient Simulator, Task Trainer, Surgical Simulator (Laparoscopy, Arthroscopy), Dental Simulator, Eye Simulator, Ultrasound Simulator, Simulation Software), End User – Global Forecast to 2025

“The medical simulation market is projected to grow at a CAGR of 14.6% between 2020 and 2025.” The global medical simulation market size is expected to reach USD 3.7 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 14.6% from 2020 to 2025. The limited access to live patients during training, advancements in medical education, increasing demand for minimally invasive treatments, increasing focus on patient safety, and growing demand for virtual training due to current COVID-19 pandemic are the major factors driving the growth of the medical simulation industry. Moreover, factors such as increasing awareness about simulation education in emerging countries and shortage of healthcare personnel are creating lucrative opportunities for the market players. “Laparoscopic sur......
$4950

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region – Global Forecast to 2025

“The microfluidics market is projected to grow at a CAGR of 22.9%.” The global microfluidics market size is projected to reach USD 44.0 billion by 2025 from USD 15.7 billion in 2020, at a CAGR of 22.9% during the forecast period. The ability of the microfluidics technology to replicate all the functions of its traditional counterparts in various healthcare applications, such as drug delivery, point-of-care (POC) diagnostics, and clinical diagnostics, is resulting in its wider adoption across the globe. In addition to this, technological advancements, increasing focus on data precision & accuracy, fast returns on investment, and faster testing & improved portability through microfluidic chip miniaturization are driving growth of the microfluidics industry. “In 2019, in-v......
$4950

Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), Disease (Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories)-Global Forecast to 2025

“The global tissue diagnostic market size is projected to register a CAGR of 6.5% during the forecast period.” The global tissue diagnostics market is expected to reach USD 4.7 billion by 2025 from USD 3.4 billion in 2020, at a CAGR of 6.5%. The growth in this market is driven by rising incidence of cancer, developing infrastructure for cancer diagnosis, the recommendation of cancer screening, availability of reimbursements, and increasing healthcare expenditure. “The consumables segment is anticipated to grow at the fastest growth rate during the forecast period” Based on product type, the tissue diagnostics market is segmented into instruments and consumables. The consumables segment is expected to grow at the highest growth rate during the forecast period. The large mar......
$4950

Biofilms Treatment Market by Products (Debridement Equipment, Gauze, Dressing, Gel, Ointment), Wound Type (Traumatic, Surgical, Open, Diabetic Foot, Venous Leg Ulcer & Burns), End User (Hospital, ASCs, Wound Care Centers, Homecare)-Global Forecast to 2025

“Rising incidence of burn injuries is driving the growth of the biofilms treatment market” The biofilms treatment market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 7.9%. The growth of this market is majorly driven by the rising prevalence of chronic, surgical, and traumatic wounds and the increasing incidence of burn injuries. However, the high cost and low adoption rate of advanced wound care products are expected to limit the growth of this market to a certain extent. “Gauzes and dressings segment accounted for the largest share of the biofilms treatment market in 2019” Based on product, the biofilms treatment market is segmented into debridement equipment; gauzes and dressings; gels, ointments, and sprays; wipes, pads, and l......
$5650
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy